Nature Communications (Apr 2022)
Bipartite network models to design combination therapies in acute myeloid leukaemia
Abstract
Identifying effective drug combinations to treat cancer is a challenging task, either experimentally or computationally. Here, the authors develop a bipartite network modelling approach to propose drug combination strategies in acute myeloid leukaemia using patient and cell line drug screening data.